Key result
EIT shows potential to monitor lesion size during RF ablation despite lacking in-vivo experiments.
Why the study?
Information on myocardial lesion growth during cardiac radiofrequency ablation is critical for safety and efficacy but unavailable, leaving real-time lesion size monitoring an unresolved clinical challenge.
Can Electrical Impedance Tomography (EIT) be used to monitor lesion size during cardiac radiofrequency ablation (CRFA)?
Can Electrical Impedance Tomography (EIT) be used to monitor lesion size during cardiac radiofrequency ablation (CRFA)?
Electrical Impedance Tomography is an emerging technology that shows potential for monitoring lesion size during cardiac radiofrequency ablation, though in-vivo experiments are still lacking.
EIT should not yet guide CRFA lesion monitoring in practice; leaves open the need for in-vivo cardiac validation studies.
Arrhythmias are common cardiac diseases which can be treated effectively by the cardiac radiofrequency ablation (CRFA). However, information regarding the lesion growth within the myocardium is critical to the procedure's safety and efficacy but still unavailable in the current catheterisation lab (CathLab). Over the last 20 years, many efforts have been made in order to track the lesion size during the procedure. Unfortunately, all the approaches have their own limitations preventing them from the clinical translation and hence making the lesion size monitoring during a CRFA still an open issue. Electrical Impedance Tomography (EIT) is an impedance imaging modality that might be able to image the thermal-related impedance changes from which the lesion size can be measured. With the availability of the patient's CT scans, for a detailed model, and the catheter-based electrodes for the internal electrodes, EIT accuracy and sensitivity to the ablated sites can be significantly improved and is worth being explored for this application. Though EIT is still new to CRFA with no in-vivo experiments being done according to our up-to-date searching, many related EIT studies and its extensive research in Hyperthermia and other ablations can reveal many hints for a possibility of the CRFA-EIT application. In this paper, we present a review on multiple aspects of EIT in CRFA. First, the expected CRFA-EIT signal range and frequency are discussed based on various measured impedance results obtained from lesions in the past. Second, the possible noise sources that can happen in a clinical CRFA procedure, along with their signal range and frequency compared to the CRFA-EIT signal, and, third, the available current solutions to separate such noises from the CRFA-EIT signal. Finally, we review the progress of EIT in thermal applications over the last two decades in order to identify the developments that EIT can take advantage of and the current drawbacks that need to be solved for a potential CRFA-EIT application.
No takes yet. Share an insight, caveat, or question.
Minh et al. (2020) conducted a review in Arrhythmias. Electrical Impedance Tomography (EIT) was evaluated. Electrical Impedance Tomography (EIT) shows potential for monitoring lesion size during cardiac radiofrequency ablation based on related thermal applications, despite lacking in-vivo experiments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: